Aquestive Therapeutics (AQST) EBIT Margin (2017 - 2026)
Aquestive Therapeutics (AQST) posted EBIT Margin of -191.46% for Q3 2026, down 101.83 percentage points from -89.63% a year earlier and down 131.96 percentage points from the prior quarter.
Aquestive Therapeutics (AQST) EBIT Margin (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBIT Margin at Aquestive Therapeutics was -114.12%, up 14.44 percentage points year-over-year; for FY2025, it came in at -159.50%, down 106.05 percentage points from FY2024.
- Annual EBIT Margin shows a five-year change of -65.95 percentage points (FY2020 to FY2025).
- In prior years, Aquestive Therapeutics' EBIT Margin was -53.46% in FY2024 (-23.60 pp), -29.86% in FY2023 (+58.37 pp), -88.23% in FY2022 (-20.00 pp) and -68.22% in FY2021 (+25.33 pp).
- Quarterly EBIT Margin has run from a low of -222.08% in Q1 2025 to a high of 0.27% in Q2 2024 over five years.
- On a year-over-year basis, EBIT Margin increased in two of the last eight quarters, with an average year-over-year change of -42.10 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q1 2026, with a gain of 192.97 percentage points; the weakest was Q1 2025, with a drop of 147.76 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -59.51% (Q2 2026), -29.10% (Q1 2026) and -221.58% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 32.98% |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn | -191.46% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -191.46% |
| Jun 30, 2026 | -59.51% |
| Mar 31, 2026 | -29.10% |
| Dec 31, 2025 | -221.58% |
| Sep 30, 2025 | -89.63% |
| Jun 30, 2025 | -113.65% |
| Mar 31, 2025 | -222.08% |
| Dec 31, 2024 | -114.43% |
| Sep 30, 2024 | -61.22% |
| Jun 30, 2024 | 0.27% |
| Mar 31, 2024 | -74.31% |
| Dec 31, 2023 | -29.62% |
| Sep 30, 2023 | -18.28% |
| Jun 30, 2023 | -31.79% |
| Mar 31, 2023 | -41.36% |
| Dec 31, 2022 | -100.29% |
| Sep 30, 2022 | -77.23% |
| Jun 30, 2022 | -96.21% |
| Mar 31, 2022 | -79.36% |
| Dec 31, 2021 | -105.33% |
Aquestive Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();